Deutsche Bank cuts Danone stock price target on formula recall impact

Deutsche Bank cut Danone’s price target to EUR65 from EUR66 and kept a Sell rating, citing 3.0% expected like-for-like growth in fiscal 2026 and just 2.4% in Q1. The firm flagged headwinds from an infant formula recall, weaker category growth, Europe category exits, normalization in China, and ongoing North America share losses. Danone is also losing share in Greek yogurt, though the stock remains near its 52-week low and still pays a dividend for 35 consecutive years.

Analysis

The cleaner read-through is not just a single-issuer downgrade; it is a signal that “defensive consumer staples” are starting to lose the valuation floor they’ve enjoyed as investors paid up for visible volume and pricing power. When a branded yogurt platform is simultaneously seeing weaker category growth, more promotions, and fading search interest, that usually means the category is sliding from scarcity economics into share-grab economics — which compresses margins faster than consensus models usually allow. The first-order hit is to the leader, but the second-order winner is the private-label and value-tier ecosystem, which can keep taking shelf space while premium brands fight for traffic with discounts.

The timing matters: the next 1-2 quarters are where the setup looks weakest because annualization won’t yet fully reflect the share losses and promotional intensity. If North America remains flat until the comp base rolls over, the market is likely to keep de-rating the story on each channel check rather than wait for reported earnings. The bigger risk is that management teams respond by leaning harder into trade spend, which can protect volumes temporarily but often leaves EBIT margins structurally lower for 2-4 quarters even if headline growth stabilizes.

The contrarian angle is that this may be more about category maturation than brand-specific collapse, which means the stock can look “cheap” on a historical multiple and still be a value trap if the terminal growth rate resets lower. However, because the market already knows the business faces recall and growth headwinds, the better expression is not an outright panic short but a relative-value trade against a more insulated staple with stronger pricing or a cleaner growth mix. If search trends for protein products remain elevated, the capital should migrate toward brands that own adjacent functionality rather than legacy yogurt franchises that are losing share despite category tailwinds.

Key Decisions for Investors

• Short DANOY into any relief rally over the next 2-6 weeks; use a tight stop above the prior breakdown zone because the stock is near long-term support, but downside can extend 10-15% if the market starts pricing in another year of promotional drag.
• Pair trade: long a higher-quality food staple with stronger mix/pricing power vs. short DANOY for 3-6 months; the edge is in relative margin resilience, not absolute category growth.
• Buy a small downside put spread on DANOY with 2-4 month expiry to express continued multiple compression while capping premium outlay; best if implied volatility remains below realized post-warning swings.
• For investors needing exposure to consumer staples, rotate away from legacy yogurt/meal-replacement names toward brands with cleaner innovation and less need for discounting; the risk/reward is materially better over the next two quarters.
• Watch for channel-check inflection on promotions and shelf resets over the next 30-60 days; if promotions keep rising, treat any bounce as a selling opportunity rather than confirmation of a durable bottom.